DCM
MURA

Davis Capital Management’s Mural Oncology MURA Stock Holding History

Davis Capital Management’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$25 Hold
20
– – ﹤0.01% 314
2024
Q4 		$64 Hold
20
– – ﹤0.01% 309
2024
Q3 		$63 Hold
20
– – ﹤0.01% 331
2024
Q2 		$62 Hold
20
– – ﹤0.01% 313
2024
Q1 		$97 Hold
20
– – ﹤0.01% 288
2023
Q4 		$118 Buy
+20
New +$80 ﹤0.01% 290

Other funds holding MURA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Davis Capital Management's MURA Position: Q1 2025 in Review

Davis Capital Management held its Mural Oncology (MURA) position steady in Q1 2025 at 20 shares worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #314.

Davis Capital Management first reported a position in MURA in Q4 2023 and has held it in 6 quarters since. The position peaked at $118 in Q4 2023. 68 funds tracked by Wall St. Rank hold MURA as of Q1 2025.

  • Davis Capital Management held 20 shares of Mural Oncology worth $25 as of Q1 2025.
  • Davis Capital Management left its Mural Oncology share count unchanged in Q1 2025.
  • Mural Oncology made up ﹤0.01% of Davis Capital Management's portfolio in Q1 2025, its #314 holding.
  • Davis Capital Management first reported a position in Mural Oncology in Q4 2023 and has held it in 6 quarters since.
  • Davis Capital Management's Mural Oncology position peaked at $118 in Q4 2023.
  • 68 funds tracked by Wall St. Rank held Mural Oncology as of Q1 2025.

Based on Davis Capital Management's 13F filing for Q1 2025, filed 11 Apr 2025.